Back to Journals » OncoTargets and Therapy » Volume 12

Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy

Total article views   HTML views PDF downloads Totals
8,632 Dovepress* 6,515+ 1,156 7,671
PubMed Central* 2,117 700 2,817
Totals 8,632 1,856 10,488
*Since 28 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar